Citius Oncology, Stock Price History

CTOR Stock   0.94  0.06  6.00%   
If you're considering investing in Citius Stock, it is important to understand the factors that can impact its price. As of today, the current price of Citius Oncology, stands at 0.94, as last reported on the 28th of November, with the highest price reaching 1.07 and the lowest price hitting 0.92 during the day. Citius Oncology, secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12% return per unit of risk over the last 3 months. Citius Oncology, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Citius Oncology,'s Standard Deviation of 6.71, risk adjusted performance of (0.09), and Mean Deviation of 4.98 to double-check the risk estimate we provide.
  
At this time, Citius Oncology,'s Total Stockholder Equity is relatively stable compared to the past year. As of 11/28/2024, Stock Based Compensation is likely to grow to about 2.4 M, while Common Stock Shares Outstanding is likely to drop slightly above 57 M. . Citius Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1214

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCTOR

Estimated Market Risk

 6.54
  actual daily
58
58% of assets are less volatile

Expected Return

 -0.79
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.12
  actual daily
0
Most of other assets perform better
Based on monthly moving average Citius Oncology, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Citius Oncology, by adding Citius Oncology, to a well-diversified portfolio.
Price Book
4.5515
Enterprise Value
116.2 M
Shares Outstanding
M
Shares Short Prior Month
10.6 K
Market Capitalization
116.2 M

Citius Oncology, Stock Price History Chart

There are several ways to analyze Citius Stock price data. The simplest method is using a basic Citius candlestick price chart, which shows Citius Oncology, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 5, 20241.88
Lowest PriceNovember 22, 20240.85

Citius Oncology, November 28, 2024 Stock Price Synopsis

Various analyses of Citius Oncology,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Citius Stock. It can be used to describe the percentage change in the price of Citius Oncology, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Citius Stock.
Citius Oncology, Price Daily Balance Of Power(0.40)
Citius Oncology, Price Action Indicator(0.09)
Citius Oncology, Accumulation Distribution 9,847 
Citius Oncology, Price Rate Of Daily Change 0.94 

Citius Oncology, November 28, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Citius Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Citius Oncology, intraday prices and daily technical indicators to check the level of noise trading in Citius Stock and then apply it to test your longer-term investment strategies against Citius.

Citius Stock Price History Data

The price series of Citius Oncology, for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 1.19 with a coefficient of variation of 22.69. The prices are distributed with arithmetic mean of 1.33. The median price for the last 90 days is 1.24.
OpenHighLowCloseVolume
11/27/2024 1.00  1.07  0.92  0.94  70,245 
11/26/2024 0.89  1.00  0.85  1.00  106,200 
11/25/2024 0.91  0.91  0.85  0.85  92,403 
11/22/2024 0.99  1.01  0.85  0.85  89,400 
11/21/2024 1.03  1.03  0.96  0.98  34,900 
11/20/2024 1.00  1.02  0.95  0.99  49,750 
11/19/2024 0.97  1.05  0.97  0.98  27,600 
11/18/2024 1.04  1.07  0.97  0.97  41,439 
11/15/2024 1.05  1.13  1.03  1.06  51,703 
11/14/2024 1.18  1.19  1.06  1.07  85,500 
11/13/2024 1.35  1.35  1.18  1.22  74,499 
11/12/2024 1.40  1.41  1.25  1.31  114,274 
11/11/2024 1.29  1.43  1.18  1.35  459,704 
11/08/2024 1.30  1.39  1.21  1.27  89,040 
11/07/2024 1.22  1.31  1.18  1.26  47,707 
11/06/2024 1.13  1.32  1.13  1.18  115,147 
11/05/2024 1.02  1.20  1.02  1.19  167,300 
11/04/2024 1.10  1.12  1.01  1.03  70,020 
11/01/2024 1.16  1.21  1.14  1.14  33,354 
10/31/2024 1.22  1.25  1.15  1.19  17,600 
10/30/2024 1.18  1.27  1.15  1.21  21,700 
10/29/2024 1.20  1.27  1.19  1.21  45,800 
10/28/2024 1.21  1.21  1.13  1.17  62,194 
10/25/2024 1.23  1.25  1.17  1.19  24,500 
10/24/2024 1.22  1.27  1.14  1.21  51,100 
10/23/2024 1.31  1.39  1.20  1.24  108,400 
10/22/2024 1.23  1.40  1.21  1.31  152,951 
10/21/2024 1.29  1.32  1.13  1.19  131,446 
10/18/2024 1.09  1.36  1.09  1.24  214,239 
10/17/2024 1.06  1.17  1.03  1.08  60,300 
10/16/2024 1.03  1.25  1.01  1.08  183,859 
10/15/2024 1.03  1.05  0.94  1.00  82,818 
10/14/2024 1.08  1.08  1.01  1.05  93,359 
10/11/2024 0.93  1.01  0.93  1.01  36,662 
10/10/2024 0.94  1.00  0.94  0.97  38,068 
10/09/2024 1.02  1.07  0.93  0.95  110,900 
10/08/2024 1.05  1.08  1.03  1.03  23,100 
10/07/2024 1.17  1.18  1.05  1.08  53,377 
10/04/2024 1.18  1.25  1.11  1.19  87,284 
10/03/2024 1.34  1.40  1.13  1.18  127,489 
10/02/2024 1.35  1.38  1.30  1.30  22,423 
10/01/2024 1.39  1.39  1.30  1.35  63,258 
09/30/2024 1.41  1.43  1.33  1.39  45,407 
09/27/2024 1.40  1.50  1.30  1.40  163,311 
09/26/2024 1.53  1.54  1.30  1.43  161,970 
09/25/2024 1.60  1.63  1.46  1.52  214,596 
09/24/2024 1.78  1.80  1.47  1.68  234,820 
09/23/2024 1.86  1.91  1.61  1.82  1,922,445 
09/20/2024 1.51  1.65  1.51  1.60  672,052 
09/19/2024 1.64  1.73  1.56  1.67  155,818 
09/18/2024 1.56  1.66  1.55  1.55  69,108 
09/17/2024 1.64  1.67  1.53  1.63  35,700 
09/16/2024 1.69  1.72  1.62  1.63  67,200 
09/13/2024 1.66  1.79  1.63  1.63  71,319 
09/12/2024 1.64  1.70  1.61  1.64  87,582 
09/11/2024 1.75  1.75  1.66  1.69  48,646 
09/10/2024 1.79  1.79  1.71  1.78  18,441 
09/09/2024 1.74  1.74  1.59  1.74  29,770 
09/06/2024 1.81  1.86  1.65  1.77  68,436 
09/05/2024 1.74  1.93  1.70  1.88  110,800 
09/04/2024 1.67  1.80  1.67  1.73  55,623 

About Citius Oncology, Stock history

Citius Oncology, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Citius is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Citius Oncology, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Citius Oncology, stock prices may prove useful in developing a viable investing in Citius Oncology,
Last ReportedProjected for Next Year
Common Stock Shares Outstanding64.1 M57 M

Citius Oncology, Stock Technical Analysis

Citius Oncology, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Citius Oncology, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Citius Oncology, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Citius Oncology, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Citius Oncology,'s price direction in advance. Along with the technical and fundamental analysis of Citius Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Citius to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Citius Stock Analysis

When running Citius Oncology,'s price analysis, check to measure Citius Oncology,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Oncology, is operating at the current time. Most of Citius Oncology,'s value examination focuses on studying past and present price action to predict the probability of Citius Oncology,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Oncology,'s price. Additionally, you may evaluate how the addition of Citius Oncology, to your portfolios can decrease your overall portfolio volatility.